{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:59:10Z","timestamp":1792792750915,"version":"4.5.0"},"reference-count":143,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Prostate International"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.prnil.2025.10.001","type":"journal-article","created":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T06:45:13Z","timestamp":1760078713000},"page":"105-115","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Therapeutic potentials of curcumin in prostate cancer: a comprehensive review of pathways and clinical prospects"],"prefix":"10.1016","volume":"14","author":[{"given":"Mohammad R.","family":"Fattahi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Shoja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad A.","family":"Mojaradi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pariya","family":"Nazarinezhad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hojat","family":"Dehghanbanadaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza","family":"Arefnezhad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1402-6482","authenticated-orcid":false,"given":"Fatemeh","family":"Rezaei-Tazangi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Habib","family":"Azimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.prnil.2025.10.001_bib1","doi-asserted-by":"crossref","first-page":"180","DOI":"10.2174\/2215083810666230815142928","article-title":"Nano-based herbal medicine: a new candidate for prostate cancer treatment?","volume":"10","author":"Pouryousefi-koodehi","year":"2024","journal-title":"Current Tradit Med"},{"issue":"2","key":"10.1016\/j.prnil.2025.10.001_bib2","first-page":"1","article-title":"Advances in focal therapy for prostate cancer: current modalities, outcomes, and future directions","volume":"7","author":"Roldan-Testillano","year":"2025","journal-title":"Prostate Int"},{"issue":"3","key":"10.1016\/j.prnil.2025.10.001_bib3","first-page":"1","article-title":"Multimodality focal therapy for prostate cancer: outcome of the \u00e0 la carte approach in clinical practice","volume":"12","author":"Yee","year":"2025","journal-title":"Prostate Int"},{"issue":"6","key":"10.1016\/j.prnil.2025.10.001_bib4","article-title":"The etiology and pathophysiology genesis of benign prostatic hyperplasia and prostate cancer: a new perspective","volume":"8","author":"Phua","year":"2021","journal-title":"Medicines (Basel)"},{"issue":"2","key":"10.1016\/j.prnil.2025.10.001_bib5","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.prnil.2024.03.003","article-title":"The impact of obesity and sexual behavior on prostate cancer risk is mediated by testosterone levels: a mendelian randomization study and mediation analysis","volume":"12","author":"Di","year":"2024","journal-title":"Prostate Int"},{"issue":"8","key":"10.1016\/j.prnil.2025.10.001_bib6","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1038\/s41416-024-02762-z","article-title":"Metabolic adaptations in prostate cancer","volume":"131","author":"Pujana-Vaquerizo","year":"2024","journal-title":"Br J Cancer"},{"issue":"6","key":"10.1016\/j.prnil.2025.10.001_bib7","doi-asserted-by":"crossref","first-page":"527","DOI":"10.4111\/icu.20240229","article-title":"Prostate cancer theragnostics biomarkers: an update","volume":"65","author":"Am","year":"2024","journal-title":"Investig Clin Urol"},{"key":"10.1016\/j.prnil.2025.10.001_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.ecoenv.2025.118209","article-title":"Revealing the role of bisphenol A on prostate cancer progression and identifying potential targets: a comprehensive analysis from population cohort to molecular mechanism","volume":"296","author":"Zhou","year":"2025","journal-title":"Ecotoxicol Environ Saf"},{"key":"10.1016\/j.prnil.2025.10.001_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2023.155258","article-title":"Inhibition of inflammation by berberine: molecular mechanism and network pharmacology analysis","volume":"128","author":"Wang","year":"2024","journal-title":"Phytomedicine"},{"issue":"1","key":"10.1016\/j.prnil.2025.10.001_bib10","doi-asserted-by":"crossref","first-page":"57","DOI":"10.56434\/j.arch.esp.urol.20247701.8","article-title":"Curcumin enhances the anti-cancer efficacy of CDK4\/6 inhibitors in prostate cancer","volume":"77","author":"Zhao","year":"2024","journal-title":"Arch Esp Urol"},{"issue":"5","key":"10.1016\/j.prnil.2025.10.001_bib11","doi-asserted-by":"crossref","DOI":"10.1002\/jbt.22049","article-title":"Curcumin suppressed the prostate cancer by inhibiting JNK pathways via epigenetic regulation","volume":"32","author":"Zhao","year":"2018","journal-title":"J Biochem Mol Toxicol"},{"issue":"9","key":"10.1016\/j.prnil.2025.10.001_bib12","doi-asserted-by":"crossref","first-page":"15616","DOI":"10.1002\/jcb.28828","article-title":"Modulation of miR-34a in curcumin-induced antiproliferation of prostate cancer cells","volume":"120","author":"Zhu","year":"2019","journal-title":"J Cell Biochem"},{"issue":"4","key":"10.1016\/j.prnil.2025.10.001_bib13","first-page":"430","article-title":"Herbal and nano-based herbal medicine: new insights into their therapeutic aspects against periodontitis","volume":"14","author":"Rezaei-Tazangi","year":"2024","journal-title":"Avicenna J Phytomed"},{"issue":"2","key":"10.1016\/j.prnil.2025.10.001_bib14","doi-asserted-by":"crossref","DOI":"10.1002\/jbt.23645","article-title":"Curcumin inhibits prostate cancer by upregulating miR-483-3p and inhibiting UBE2C","volume":"38","author":"Li","year":"2024","journal-title":"J Biochem Mol Toxicol"},{"issue":"2","key":"10.1016\/j.prnil.2025.10.001_bib15","article-title":"Curcumin: biological activities and modern pharmaceutical forms","volume":"11","author":"Uro\u0161evi\u0107","year":"2022","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.prnil.2025.10.001_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.jff.2023.105705","article-title":"Curcumin and its novel formulations for the treatment of hepatocellular carcinoma: new trends and future perspectives in cancer therapy","volume":"108","author":"Meybodi","year":"2023","journal-title":"J Funct Foods"},{"issue":"1","key":"10.1016\/j.prnil.2025.10.001_bib17","doi-asserted-by":"crossref","first-page":"57","DOI":"10.56434\/j.arch.esp.urol.20247701.8","article-title":"Curcumin enhances the anti-cancer efficacy of CDK4\/6 inhibitors in prostate cancer","volume":"77","author":"Zhao","year":"2024","journal-title":"Arch Esp Urol"},{"key":"10.1016\/j.prnil.2025.10.001_bib18","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2020.572533","article-title":"Curcumin in depression: potential mechanisms of action and current Evidence-A narrative review","volume":"11","author":"Ramaholimihaso","year":"2020","journal-title":"Front Psychiatr"},{"issue":"5","key":"10.1016\/j.prnil.2025.10.001_bib19","first-page":"1050","article-title":"Curcumin (Turmeric) and cancer","volume":"21","author":"Unlu","year":"2016","journal-title":"J buon"},{"issue":"8","key":"10.1016\/j.prnil.2025.10.001_bib20","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1089\/jmf.2016.3705","article-title":"Efficacy of turmeric extracts and curcumin for alleviating the symptoms of joint arthritis: a systematic review and meta-analysis of randomized clinical trials","volume":"19","author":"Daily","year":"2016","journal-title":"J Med Food"},{"issue":"7","key":"10.1016\/j.prnil.2025.10.001_bib21","doi-asserted-by":"crossref","DOI":"10.3390\/nu10070855","article-title":"Curcumin in liver diseases: a systematic review of the cellular mechanisms of oxidative stress and clinical perspective","volume":"10","author":"Farzaei","year":"2018","journal-title":"Nutrients"},{"key":"10.1016\/j.prnil.2025.10.001_bib22","doi-asserted-by":"crossref","first-page":"165","DOI":"10.2147\/DDDT.S445555","article-title":"Review of the protective mechanism of curcumin on cardiovascular disease","volume":"18","author":"Yang","year":"2024","journal-title":"Drug Des Devel Ther"},{"key":"10.1016\/j.prnil.2025.10.001_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctim.2023.102955","article-title":"Effects of curcumin\/turmeric supplementation on lipid profile: a GRADE-assessed systematic review and dose-response meta-analysis of randomized controlled trials","volume":"75","author":"Dehzad","year":"2023","journal-title":"Compl Ther Med"},{"issue":"8","key":"10.1016\/j.prnil.2025.10.001_bib24","doi-asserted-by":"crossref","DOI":"10.3390\/nu11081837","article-title":"Curcumin and type 2 diabetes mellitus: prevention and treatment","volume":"11","author":"Pivari","year":"2019","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.prnil.2025.10.001_bib25","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/s12876-019-1055-4","article-title":"Curcumin and inflammation in non-alcoholic fatty liver disease: a randomized, placebo controlled clinical trial","volume":"19","author":"Saadati","year":"2019","journal-title":"BMC Gastroenterol"},{"issue":"1","key":"10.1016\/j.prnil.2025.10.001_bib26","doi-asserted-by":"crossref","DOI":"10.1002\/fsn3.4144","article-title":"Therapeutic effects of curcumin supplementation on liver enzymes of nonalcoholic fatty liver disease patients: a systematic review and meta-analysis of randomized clinical trials","volume":"13","author":"Ebrahimzadeh","year":"2025","journal-title":"Food Sci Nutr"},{"issue":"10","key":"10.1016\/j.prnil.2025.10.001_bib27","doi-asserted-by":"crossref","DOI":"10.3390\/nu11102376","article-title":"Curcumin and cancer","volume":"11","author":"Giordano","year":"2019","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.prnil.2025.10.001_bib28","doi-asserted-by":"crossref","first-page":"8323","DOI":"10.1038\/s41598-018-25524-3","article-title":"Curcumin decreases Warburg effect in cancer cells by down-regulating pyruvate kinase M2 via mTOR-HIF1\u03b1 inhibition","volume":"8","author":"Siddiqui","year":"2018","journal-title":"Sci Rep"},{"issue":"4","key":"10.1016\/j.prnil.2025.10.001_bib29","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1007\/s11596-011-0485-1","article-title":"Anti-tumor activity of curcumin against androgen-independent prostate cancer cells via inhibition of NF-\u03baB and AP-1 pathway in vitro","volume":"31","author":"Liu","year":"2011","journal-title":"J Huazhong Univ Sci Technol Med Sci"},{"issue":"4","key":"10.1016\/j.prnil.2025.10.001_bib30","first-page":"1635","article-title":"Curcumin inhibits proliferation and invasion of papillary thyroid carcinoma cells by inhibiting the JAK2\/STAT3 pathway","volume":"26","author":"Hu","year":"2021","journal-title":"J buon"},{"issue":"1","key":"10.1016\/j.prnil.2025.10.001_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11033-025-10448-9","article-title":"Dose-dependent effects of curcumin on 22Rv1 prostate cancer cell line","volume":"52","author":"Tossetta","year":"2025","journal-title":"Mol Biol Rep"},{"key":"10.1016\/j.prnil.2025.10.001_bib32","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1002\/mc.70000","article-title":"Synergistic inhibition of prostate cancer progression in mice with a combination of curcumin and ursolic acid in the diet","volume":"64","author":"Friedman","year":"2025","journal-title":"Mol Carcinog"},{"issue":"3","key":"10.1016\/j.prnil.2025.10.001_bib33","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.prnil.2025.10.001_bib34","series-title":"Prostate cancer. StatPearls. Treasure island (FL): Statpearls publishing copyright \u00a9 2024","author":"Leslie","year":"2024"},{"key":"10.1016\/j.prnil.2025.10.001_bib35","series-title":"Prostate cancer","year":"2021"},{"issue":"S1","key":"10.1016\/j.prnil.2025.10.001_bib36","doi-asserted-by":"crossref","first-page":"S110","DOI":"10.1038\/modpathol.2017.158","article-title":"Treatment effects in prostate cancer","volume":"31","author":"Evans","year":"2018","journal-title":"Mod Pathol"},{"key":"10.1016\/j.prnil.2025.10.001_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2024.122469","article-title":"Nanotherapeutics for prostate cancer treatment: a comprehensive review","volume":"305","author":"Hu","year":"2024","journal-title":"Biomaterials"},{"issue":"Pt A","key":"10.1016\/j.prnil.2025.10.001_bib38","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.mce.2017.06.007","article-title":"Bromodomain-containing proteins in prostate cancer","volume":"462","author":"Urbanucci","year":"2018","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.prnil.2025.10.001_bib39","first-page":"341","article-title":"Epigenetics in prostate cancer treatment","volume":"5","author":"Jones","year":"2021","journal-title":"J Transl Genet Genom"},{"issue":"11","key":"10.1016\/j.prnil.2025.10.001_bib40","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.201910659","article-title":"The novel BET-CBP\/p300 dual inhibitor NEO2734 is active in SPOP mutant and wild-type prostate cancer","volume":"11","author":"Yan","year":"2019","journal-title":"EMBO Mol Med"},{"issue":"1","key":"10.1016\/j.prnil.2025.10.001_bib41","first-page":"99","article-title":"PROTAC technology for prostate cancer treatment","volume":"4","author":"Zhen Wang","year":"2025","journal-title":"Acta Materia Medica"},{"issue":"2","key":"10.1016\/j.prnil.2025.10.001_bib42","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S1470-2045(23)00638-1","article-title":"Actinium-225-PSMA radioligand therapy of metastatic castration-resistant prostate cancer (WARMTH Act): a multicentre, retrospective study","volume":"25","author":"Sathekge","year":"2024","journal-title":"Lancet Oncol"},{"issue":"21","key":"10.1016\/j.prnil.2025.10.001_bib43","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13215417","article-title":"Androgen receptor signaling in prostate cancer and therapeutic strategies","volume":"13","author":"Jacob","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"12","key":"10.1016\/j.prnil.2025.10.001_bib44","doi-asserted-by":"crossref","DOI":"10.3390\/cells9122653","article-title":"Androgen receptor signaling pathway in prostate cancer: from genetics to clinical applications","volume":"9","author":"Aurilio","year":"2020","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.prnil.2025.10.001_bib45","doi-asserted-by":"crossref","first-page":"R15","DOI":"10.1530\/JME-14-0203","article-title":"Androgens and androgen receptor signaling in prostate tumorigenesis","volume":"54","author":"Zhou","year":"2015","journal-title":"J Mol Endocrinol"},{"issue":"20","key":"10.1016\/j.prnil.2025.10.001_bib46","doi-asserted-by":"crossref","DOI":"10.3390\/ijms242015085","article-title":"Cancer stem cells and androgen receptor signaling: partners in disease progression","volume":"24","author":"Quintero","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"6","key":"10.1016\/j.prnil.2025.10.001_bib47","doi-asserted-by":"crossref","first-page":"431","DOI":"10.31083\/ph.2013.2861","article-title":"Curcumin induces cell cycle arrest and apoptosis of prostate cancer cells by regulating the expression of IkappaBalpha, c-Jun and androgen receptor","volume":"68","author":"Guo","year":"2013","journal-title":"Pharmazie"},{"issue":"4","key":"10.1016\/j.prnil.2025.10.001_bib48","first-page":"825","article-title":"Curcumin down-regulates AR gene expression and activation in prostate cancer cell lines","volume":"21","author":"Nakamura","year":"2002","journal-title":"Int J Oncol"},{"key":"10.1016\/j.prnil.2025.10.001_bib49","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1224892","article-title":"The potential of activator protein 1 (AP-1) in cancer targeted therapy","volume":"14","author":"Song","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.prnil.2025.10.001_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.117225","article-title":"A multi-omics approach to reveal critical mechanisms of activator protein 1 (AP-1)","volume":"178","author":"Li","year":"2024","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"10.1016\/j.prnil.2025.10.001_bib51","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s12672-025-01783-1","article-title":"Advances in the relationship between AP-1 and tumorigenesis, development and therapy resistance","volume":"16","author":"Xue","year":"2025","journal-title":"Discov Oncol"},{"issue":"52","key":"10.1016\/j.prnil.2025.10.001_bib52","doi-asserted-by":"crossref","first-page":"7597","DOI":"10.1038\/sj.onc.1204997","article-title":"Curcumin downregulates cell survival mechanisms in human prostate cancer cell lines","volume":"20","author":"Mukhopadhyay","year":"2001","journal-title":"Oncogene"},{"issue":"2","key":"10.1016\/j.prnil.2025.10.001_bib53","doi-asserted-by":"crossref","DOI":"10.3390\/cells5020016","article-title":"The NF-\u03baB pathway and cancer stem cells","volume":"5","author":"Rinkenbaugh","year":"2016","journal-title":"Cells"},{"issue":"4","key":"10.1016\/j.prnil.2025.10.001_bib54","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1002\/mco2.104","article-title":"NF-\u03baB signaling in inflammation and cancer","volume":"2","author":"Zhang","year":"2021","journal-title":"MedComm"},{"issue":"1","key":"10.1016\/j.prnil.2025.10.001_bib55","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1186\/s40001-024-02168-w","article-title":"NF-\u03baB pathway and angiogenesis: insights into colorectal cancer development and therapeutic targets","volume":"29","author":"Bahrami","year":"2024","journal-title":"Eur J Med Res"},{"issue":"1","key":"10.1016\/j.prnil.2025.10.001_bib56","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1007\/s00018-023-05098-8","article-title":"Targeting the NF-\u03baB pathway as a potential regulator of immune checkpoints in cancer immunotherapy","volume":"81","author":"Ebrahimi","year":"2024","journal-title":"Cell Mol Life Sci"},{"issue":"8","key":"10.1016\/j.prnil.2025.10.001_bib57","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines9080889","article-title":"NF-\u03baB and human cancer: what have we learned over the past 35 years?","volume":"9","author":"Gilmore","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.prnil.2025.10.001_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2023.106775","article-title":"Malignant function of nuclear factor-kappaB axis in prostate cancer: molecular interactions and regulation by non-coding RNAs","volume":"194","author":"Al-Rashidi","year":"2023","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.prnil.2025.10.001_bib59","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1007\/s12253-011-9396-5","article-title":"Classical and alternative nuclear factor-\u03baB pathways: a comparison among normal prostate, benign prostate hyperplasia and prostate cancer","volume":"17","author":"Cai","year":"2011","journal-title":"Pathol Oncol Res"},{"issue":"12","key":"10.1016\/j.prnil.2025.10.001_bib60","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1093\/carcin\/bgs312","article-title":"Curcumin inhibits prostate cancer metastasis in vivo by targeting the inflammatory cytokines CXCL1 and -2","volume":"33","author":"Killian","year":"2012","journal-title":"Carcinogenesis"},{"issue":"19","key":"10.1016\/j.prnil.2025.10.001_bib61","doi-asserted-by":"crossref","DOI":"10.3390\/ijms231911502","article-title":"miRNA: a promising therapeutic target in cancer","volume":"23","author":"Menon","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"4","key":"10.1016\/j.prnil.2025.10.001_bib62","doi-asserted-by":"crossref","first-page":"463","DOI":"10.2174\/1568009623666230817102104","article-title":"mirna-383-5p functions as an anti-oncogene in glioma through the Akt\/mTOR signaling pathway by targeting VEGFA","volume":"24","author":"Liu","year":"2024","journal-title":"Curr Cancer Drug Targets"},{"issue":"5","key":"10.1016\/j.prnil.2025.10.001_bib63","article-title":"Regulatory mechanism of MicroRNA expression in cancer","volume":"21","author":"Ali","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"12","key":"10.1016\/j.prnil.2025.10.001_bib64","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.1038\/bjc.2013.250","article-title":"The loss of the tumour-suppressor miR-145 results in the shorter disease-free survival of prostate cancer patients","volume":"108","author":"Avgeris","year":"2013","journal-title":"Br J Cancer"},{"issue":"4","key":"10.1016\/j.prnil.2025.10.001_bib65","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1042\/EBC20200032","article-title":"Non-coding RNA in cancer","volume":"65","author":"Yan","year":"2021","journal-title":"Essays Biochem"},{"issue":"1","key":"10.1016\/j.prnil.2025.10.001_bib66","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.clgc.2011.05.008","article-title":"Comparison of circulating MicroRNA 141 to circulating tumor cells, lactate dehydrogenase, and prostate-specific antigen for determining treatment response in patients with metastatic prostate cancer","volume":"9","author":"Gonzales","year":"2011","journal-title":"Clin Genitourin Cancer"},{"issue":"5","key":"10.1016\/j.prnil.2025.10.001_bib67","doi-asserted-by":"crossref","first-page":"350","DOI":"10.7150\/jca.6394","article-title":"Comprehensive microRNA profiling of prostate cancer","volume":"4","author":"Walter","year":"2013","journal-title":"J Cancer"},{"issue":"1","key":"10.1016\/j.prnil.2025.10.001_bib68","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1080\/21691401.2018.1553783","article-title":"MiR-30a-5p frequently downregulated in prostate cancer inhibits cell proliferation via targeting PCLAF","volume":"47","author":"Zhao","year":"2019","journal-title":"Artif Cells, Nanomed Biotechnol"},{"issue":"11","key":"10.1016\/j.prnil.2025.10.001_bib69","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1002\/pros.23187","article-title":"Association of microRNA-21 expression with clinicopathological characteristics and the risk of progression in advanced prostate cancer patients receiving androgen deprivation therapy","volume":"76","author":"Guan","year":"2016","journal-title":"Prostate"},{"issue":"19","key":"10.1016\/j.prnil.2025.10.001_bib70","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1038\/onc.2016.419","article-title":"MicroRNA-383 located in frequently deleted chromosomal locus 8p22 regulates CD44 in prostate cancer","volume":"36","author":"Bucay","year":"2017","journal-title":"Oncogene"},{"key":"10.1016\/j.prnil.2025.10.001_bib71","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2019.109390","article-title":"Relevance function of microRNA-708 in the pathogenesis of cancer","volume":"63","author":"Sun","year":"2019","journal-title":"Cell Signal"},{"issue":"3","key":"10.1016\/j.prnil.2025.10.001_bib72","doi-asserted-by":"crossref","first-page":"969","DOI":"10.3892\/etm.2021.10401","article-title":"Curcumin inhibits prostate cancer progression by regulating the miR-30a-5p\/PCLAF axis","volume":"22","author":"Pan","year":"2021","journal-title":"Exp Ther Med"},{"issue":"4","key":"10.1016\/j.prnil.2025.10.001_bib73","first-page":"429","article-title":"Cytotoxicity of curcumin against CD44(\u00b1) prostate cancer cells: roles of miR-383 and miR-708","volume":"13","author":"Panahizadeh","year":"2023","journal-title":"Avicenna J Phytomed"},{"issue":"8","key":"10.1016\/j.prnil.2025.10.001_bib74","article-title":"The curcumin analog EF24 targets NF-\u03baB and miRNA-21, and has potent anticancer activity in vitro and in vivo","volume":"8","author":"Yang","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.prnil.2025.10.001_bib75","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.gene.2017.08.008","article-title":"Curcumin suppresses proliferation and in vitro invasion of human prostate cancer stem cells by ceRNA effect of miR-145 and lncRNA-ROR","volume":"631","author":"Liu","year":"2017","journal-title":"Gene"},{"issue":"3","key":"10.1016\/j.prnil.2025.10.001_bib76","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/s41419-019-1407-6","article-title":"BCL-2 family isoforms in apoptosis and cancer","volume":"10","author":"Warren","year":"2019","journal-title":"Cell Death Dis"},{"issue":"1","key":"10.1016\/j.prnil.2025.10.001_bib77","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/cdd.2017.186","article-title":"BCL-2 family proteins: changing partners in the dance towards death","volume":"25","author":"Kale","year":"2018","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.prnil.2025.10.001_bib78","doi-asserted-by":"crossref","DOI":"10.4111\/icu.20250310","article-title":"Induction of apoptosis and growth inhibition by silodosin and abiraterone acetate in PC-3 human prostate cancer cells","volume":"66","author":"Hakim","year":"2025","journal-title":"Investig Clin Urol"},{"issue":"50","key":"10.1016\/j.prnil.2025.10.001_bib79","doi-asserted-by":"crossref","first-page":"6398","DOI":"10.1038\/onc.2008.307","article-title":"Bcl-2 family proteins and cancer","volume":"27","author":"Yip","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.prnil.2025.10.001_bib80","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.biopha.2016.09.037","article-title":"Curcumin induces G0\/G1 arrest and apoptosis in hormone independent prostate cancer DU-145 cells by down regulating Notch signaling","volume":"84","author":"Sha","year":"2016","journal-title":"Biomed Pharmacother"},{"issue":"4","key":"10.1016\/j.prnil.2025.10.001_bib81","first-page":"905","article-title":"Involvement of Bcl-2 family members, phosphatidylinositol 3'-kinase\/AKT and mitochondrial p53 in curcumin (diferulolylmethane)-induced apoptosis in prostate cancer","volume":"30","author":"Shankar","year":"2007","journal-title":"Int J Oncol"},{"issue":"3","key":"10.1016\/j.prnil.2025.10.001_bib82","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24032046","article-title":"AR and PI3K\/AKT in prostate cancer: a tale of two interconnected pathways","volume":"24","author":"Tortorella","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"21","key":"10.1016\/j.prnil.2025.10.001_bib83","doi-asserted-by":"crossref","DOI":"10.1002\/cam4.70354","article-title":"Important roles of PI3K\/AKT signaling pathway and relevant inhibitors in prostate cancer progression","volume":"13","author":"Wang","year":"2024","journal-title":"Cancer Med"},{"issue":"1","key":"10.1016\/j.prnil.2025.10.001_bib84","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s12943-019-0954-x","article-title":"Targeting PI3K in cancer: mechanisms and advances in clinical trials","volume":"18","author":"Yang","year":"2019","journal-title":"Mol Cancer"},{"key":"10.1016\/j.prnil.2025.10.001_bib85","article-title":"PI3K\/Akt\/mTOR pathway and its role in cancer therapeutics: are we making headway?","volume":"12","author":"Peng","year":"2022","journal-title":"Front Oncol"},{"issue":"4","key":"10.1016\/j.prnil.2025.10.001_bib86","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s12282-024-01567-5","article-title":"PI3K\/AKT\/mTOR signaling pathway: an important driver and therapeutic target in triple-negative breast cancer","volume":"31","author":"Zhang","year":"2024","journal-title":"Breast Cancer"},{"issue":"6","key":"10.1016\/j.prnil.2025.10.001_bib87","doi-asserted-by":"crossref","first-page":"4587","DOI":"10.1007\/s11033-020-05435-1","article-title":"Role of PI3K\/AKT pathway in cancer: the framework of malignant behavior","volume":"47","author":"Jiang","year":"2020","journal-title":"Mol Biol Rep"},{"issue":"1","key":"10.1016\/j.prnil.2025.10.001_bib88","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1186\/s13046-024-03207-4","article-title":"AKT kinases as therapeutic targets","volume":"43","author":"Hassan","year":"2024","journal-title":"J Exp Clin Cancer Res"},{"issue":"19","key":"10.1016\/j.prnil.2025.10.001_bib89","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20194891","article-title":"Curcumin-gene expression response in hormone dependent and independent metastatic prostate cancer cells","volume":"20","author":"Katta","year":"2019","journal-title":"Int J Mol Sci"},{"issue":"9","key":"10.1016\/j.prnil.2025.10.001_bib90","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1158\/1535-7163.MCT-07-2400","article-title":"Curcumin inhibits Akt\/mammalian target of rapamycin signaling through protein phosphatase-dependent mechanism","volume":"7","author":"Yu","year":"2008","journal-title":"Mol Cancer Ther"},{"issue":"1","key":"10.1016\/j.prnil.2025.10.001_bib91","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s13045-024-01563-4","article-title":"Wnt\/\u03b2-catenin signaling pathway in carcinogenesis and cancer therapy","volume":"17","author":"Song","year":"2024","journal-title":"J Hematol Oncol"},{"issue":"16","key":"10.1016\/j.prnil.2025.10.001_bib92","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e35989","article-title":"Blocking the WNT\/\u03b2-catenin pathway in cancer treatment:pharmacological targets and drug therapeutic potential","volume":"10","author":"Zhao","year":"2024","journal-title":"Heliyon"},{"issue":"2","key":"10.1016\/j.prnil.2025.10.001_bib93","doi-asserted-by":"crossref","DOI":"10.3390\/biology14020185","article-title":"Overview of Wnt\/\u03b2-Catenin pathway and DNA Damage\/Repair in cancer","volume":"14","author":"Nadin","year":"2025","journal-title":"Biology"},{"issue":"1","key":"10.1016\/j.prnil.2025.10.001_bib94","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/s13045-020-00990-3","article-title":"Targeting the Wnt\/\u03b2-catenin signaling pathway in cancer","volume":"13","author":"Zhang","year":"2020","journal-title":"J Hematol Oncol"},{"issue":"2","key":"10.1016\/j.prnil.2025.10.001_bib95","first-page":"101","article-title":"Wnt signaling and colorectal cancer","volume":"13","author":"Schatoff","year":"2017","journal-title":"Curr Colorectal Cancer Rep"},{"key":"10.1016\/j.prnil.2025.10.001_bib96","doi-asserted-by":"crossref","first-page":"4020","DOI":"10.2741\/2368","article-title":"Wnt pathway and breast cancer","volume":"12","author":"Mohinta","year":"2007","journal-title":"Front Biosci"},{"issue":"7","key":"10.1016\/j.prnil.2025.10.001_bib97","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.7150\/jca.22005","article-title":"Wnt signaling in cervical cancer?","volume":"9","author":"Yang","year":"2018","journal-title":"J Cancer"},{"issue":"1","key":"10.1016\/j.prnil.2025.10.001_bib98","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3892\/mco.2024.2743","article-title":"Wnt signaling and tumors","volume":"21","author":"Wang","year":"2024","journal-title":"Mol Clin Oncol"},{"key":"10.1016\/j.prnil.2025.10.001_bib99","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2024.1410513","article-title":"Wnt signaling in gastric cancer: current progress and future prospects","volume":"14","author":"Han","year":"2024","journal-title":"Front Oncol"},{"issue":"1","key":"10.1016\/j.prnil.2025.10.001_bib100","doi-asserted-by":"crossref","first-page":"94","DOI":"10.2174\/1568009623666230413094317","article-title":"Wnt\/\u03b2-catenin signaling in lung cancer: association with proliferation, metastasis, and therapy resistance","volume":"24","author":"Entezari","year":"2023","journal-title":"Curr Cancer Drug Targets"},{"issue":"5","key":"10.1016\/j.prnil.2025.10.001_bib101","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s40495-023-00333-z","article-title":"Wnt signaling and therapeutic resistance in castration-resistant prostate cancer","volume":"9","author":"Kishore","year":"2023","journal-title":"Curr Pharmacol Rep"},{"issue":"3","key":"10.1016\/j.prnil.2025.10.001_bib102","first-page":"603","article-title":"Anti-proliferative potential of curcumin in androgen-dependent prostate cancer cells occurs through modulation of the Wingless signaling pathway","volume":"38","author":"Teiten","year":"2011","journal-title":"Int J Oncol"},{"issue":"4","key":"10.1016\/j.prnil.2025.10.001_bib103","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/pcan.2010.26","article-title":"Curcumin interrupts the interaction between the androgen receptor and Wnt\/\u03b2-catenin signaling pathway in LNCaP prostate cancer cells","volume":"13","author":"Choi","year":"2010","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"6","key":"10.1016\/j.prnil.2025.10.001_bib104","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1080\/01635581.2020.1783327","article-title":"Combination of curcumin and metformin inhibits cell growth and induces apoptosis without affecting the cell cycle in LNCaP prostate cancer cell line","volume":"73","author":"Eslami","year":"2021","journal-title":"Nutr Cancer"},{"issue":"8","key":"10.1016\/j.prnil.2025.10.001_bib105","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1055\/a-1867-4805","article-title":"Curcumin upregulates miR-148a to increase the chemosensitivity of CD44-Positive prostate cancer stem cells to paclitaxel through targeting the MSK1\/IRS1 axis","volume":"72","author":"Vatankhah","year":"2022","journal-title":"Drug Res"},{"issue":"7","key":"10.1016\/j.prnil.2025.10.001_bib106","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1080\/1061186X.2017.1315686","article-title":"Curcumin sensitizes prostate cancer cells to radiation partly via epigenetic activation of miR-143 and miR-143 mediated autophagy inhibition","volume":"25","author":"Liu","year":"2017","journal-title":"J Drug Target"},{"key":"10.1016\/j.prnil.2025.10.001_bib107","first-page":"171","article-title":"Synergistic effect between curcumin (diferuloylmethane) and radiation on clonogenic cell death independent of p53 in prostate cancer cells. J cancer Sci Ther 2: 171-181. doi: 10.4172\/1948-5956.1000046","volume":"5956","author":"Nayak","year":"1948","journal-title":"OMICS Publishing Group J Cancer Sci Ther ISSN"},{"issue":"18","key":"10.1016\/j.prnil.2025.10.001_bib108","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22189966","article-title":"Growth, proliferation and metastasis of prostate cancer cells is blocked by low-dose curcumin in combination with light irradiation","volume":"22","author":"Rutz","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"4","key":"10.1016\/j.prnil.2025.10.001_bib109","first-page":"485","article-title":"Chinese herbal medicines for prostate cancer therapy: from experimental research to clinical practice","volume":"15","author":"Kong","year":"2023","journal-title":"Chin Herb Med"},{"issue":"3","key":"10.1016\/j.prnil.2025.10.001_bib110","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1007\/s13577-020-00337-7","article-title":"Chemopreventive effects of nanoparticle curcumin in a mouse model ofPten-deficient prostate cancer","volume":"33","author":"De Velasco","year":"2020","journal-title":"Hum Cell"},{"issue":"30","key":"10.1016\/j.prnil.2025.10.001_bib111","doi-asserted-by":"crossref","first-page":"8635","DOI":"10.1016\/j.biomaterials.2014.06.040","article-title":"Anti-cancer activity of curcumin loaded nanoparticles in prostate cancer","volume":"35","author":"Yallapu","year":"2014","journal-title":"Biomaterials"},{"issue":"9","key":"10.1016\/j.prnil.2025.10.001_bib112","doi-asserted-by":"crossref","first-page":"656","DOI":"10.4111\/kju.2015.56.9.656","article-title":"Effect of curcumin on the interaction between androgen receptor and Wnt\/\u03b2-catenin in LNCaP xenografts","volume":"56","author":"Hong","year":"2015","journal-title":"Korean J Urol"},{"issue":"8","key":"10.1016\/j.prnil.2025.10.001_bib113","first-page":"9272","article-title":"Effect of curcumin on Bcl-2 and Bax expression in nude mice prostate cancer","volume":"8","author":"Yang","year":"2015","journal-title":"Int J Clin Exp Pathol"},{"issue":"5","key":"10.1016\/j.prnil.2025.10.001_bib114","doi-asserted-by":"crossref","DOI":"10.1002\/jbt.22049","article-title":"Curcumin suppressed the prostate cancer by inhibiting JNK pathways via epigenetic regulation","volume":"32","author":"Zhao","year":"2018","journal-title":"J Biochem Mol Toxicol"},{"issue":"4","key":"10.1016\/j.prnil.2025.10.001_bib115","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1002\/pros.1074","article-title":"Therapeutic potential of curcumin in human prostate cancer. III. Curcumin inhibits proliferation, induces apoptosis, and inhibits angiogenesis of LNCaP prostate cancer cells in vivo","volume":"47","author":"Dorai","year":"2001","journal-title":"Prostate"},{"key":"10.1016\/j.prnil.2025.10.001_bib116","doi-asserted-by":"crossref","first-page":"637","DOI":"10.3389\/fphar.2020.00637","article-title":"The curcumin derivative, H10, suppresses hormone-dependent prostate cancer by inhibiting 17\u03b2-Hydroxysteroid dehydrogenase type 3","volume":"11","author":"Cheng","year":"2020","journal-title":"Front Pharmacol"},{"issue":"2","key":"10.1016\/j.prnil.2025.10.001_bib117","doi-asserted-by":"crossref","DOI":"10.1177\/03000605231220807","article-title":"Curcumin inhibits growth and triggers apoptosis in human castration-resistant prostate cancer cells via IGF-1\/PI3K\/Akt pathway","volume":"53","author":"Chen","year":"2025","journal-title":"J Int Med Res"},{"issue":"7","key":"10.1016\/j.prnil.2025.10.001_bib118","first-page":"590","article-title":"[Effects of curcumin on tumor growth and immune function in prostate cancer-bearing mice]","volume":"25","author":"Mao","year":"2019","journal-title":"Zhonghua Nan ke Xue"},{"issue":"2","key":"10.1016\/j.prnil.2025.10.001_bib119","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1159\/000441148","article-title":"The new combination docetaxel, prednisone and curcumin in patients with castration-resistant prostate cancer: a pilot phase II Study","volume":"90","author":"Mahammedi","year":"2016","journal-title":"Oncology"},{"issue":"2","key":"10.1016\/j.prnil.2025.10.001_bib120","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1002\/ptr.6230","article-title":"Randomized, double-blind, placebo-controlled phase II trial of nanocurcumin in prostate cancer patients undergoing radiotherapy","volume":"33","author":"Saadipoor","year":"2019","journal-title":"Phytother Res"},{"issue":"1","key":"10.1016\/j.prnil.2025.10.001_bib121","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1080\/01635581.2016.1115527","article-title":"Effect of curcumin supplementation during radiotherapy on oxidative status of patients with prostate cancer: a double blinded, randomized, placebo-controlled study","volume":"68","author":"Hejazi","year":"2016","journal-title":"Nutr Cancer"},{"issue":"6","key":"10.1016\/j.prnil.2025.10.001_bib122","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1002\/pros.23766","article-title":"A randomized, double-blind, placebo-controlled trial to evaluate the role of curcumin in prostate cancer patients with intermittent androgen deprivation","volume":"79","author":"Choi","year":"2019","journal-title":"Prostate"},{"key":"10.1016\/j.prnil.2025.10.001_bib123","series-title":"Randomized trial of adjuvant curcumin after prostatectomy","year":"2014"},{"key":"10.1016\/j.prnil.2025.10.001_bib124","series-title":"A randomized, double-blind, placebo-controlled trial of curcumin to prevent progression of biopsy proven, low-risk localized prostate cancer patients undergoing active surveillance","year":"2018"},{"issue":"5","key":"10.1016\/j.prnil.2025.10.001_bib125","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.jtcme.2024.03.002","article-title":"Phase 1 clinical trial evaluating safety, bioavailability, and gut microbiome with a combination of curcumin and ursolic acid in lipid enhanced capsules","volume":"14","author":"Liss","year":"2024","journal-title":"J Tradit Complement Med"},{"issue":"7","key":"10.1016\/j.prnil.2025.10.001_bib126","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1002\/cam4.3806","article-title":"Multicenter randomized phase II study comparing docetaxel plus curcumin versus docetaxel plus placebo in first-line treatment of metastatic castration-resistant prostate cancer","volume":"10","author":"Passildas-Jahanmohan","year":"2021","journal-title":"Cancer Med"},{"key":"10.1016\/j.prnil.2025.10.001_bib127","series-title":"Dimethyl curcumin-loaded polymer micelle and application thereof [Internet]","year":"2024"},{"key":"10.1016\/j.prnil.2025.10.001_bib128","series-title":"Pharmaceutical composition comprising curcumin and resveratrol and uses thereof in medical field [Internet]","year":"2006"},{"key":"10.1016\/j.prnil.2025.10.001_bib129","series-title":"Application of curcumin derivative in preparation of drug for treating prostate cancer disease [Internet]","year":"2011"},{"key":"10.1016\/j.prnil.2025.10.001_bib130","series-title":"Curcumin derivative as well as preparation method and application thereof [Internet]","year":"2023"},{"key":"10.1016\/j.prnil.2025.10.001_bib131","series-title":"Therapeutic uses of curcumin analogs for treatment of prostate cancer [Internet]","year":"2015"},{"key":"10.1016\/j.prnil.2025.10.001_bib132","series-title":"Nano-silver target drug feeding system loaded with curcumin or curcumin derivative [Internet]","year":"2016"},{"key":"10.1016\/j.prnil.2025.10.001_bib133","series-title":"Curcumin derivative, synthetic method thereof and application of curcumin derivative in anti-androgen receptor [Internet]","year":"2023"},{"issue":"9","key":"10.1016\/j.prnil.2025.10.001_bib134","doi-asserted-by":"crossref","DOI":"10.3390\/antiox13091092","article-title":"A review of recent curcumin analogues and their antioxidant, Anti-Inflammatory, and anticancer activities","volume":"13","author":"Kaur","year":"2024","journal-title":"Antioxidants"},{"issue":"22","key":"10.1016\/j.prnil.2025.10.001_bib135","doi-asserted-by":"crossref","DOI":"10.3390\/molecules29225321","article-title":"Curcumin derivatives in medicinal chemistry: potential applications in cancer treatment","volume":"29","author":"Kuzminska","year":"2024","journal-title":"Molecules"},{"issue":"3","key":"10.1016\/j.prnil.2025.10.001_bib136","doi-asserted-by":"crossref","DOI":"10.3390\/antiox13030331","article-title":"Enhancing the bioavailability and bioactivity of curcumin for disease prevention and treatment","volume":"13","author":"Bertoncini-Silva","year":"2024","journal-title":"Antioxidants"},{"issue":"1-2","key":"10.1016\/j.prnil.2025.10.001_bib137","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.jchromb.2007.03.010","article-title":"Oral bioavailability of curcumin in rat and the herbal analysis from Curcuma longa by LC-MS\/MS","volume":"853","author":"Yang","year":"2007","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"issue":"4","key":"10.1016\/j.prnil.2025.10.001_bib138","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1002\/ptr.7737","article-title":"Curcumin-piperine co-supplementation and human health: a comprehensive review of preclinical and clinical studies","volume":"37","author":"Heidari","year":"2023","journal-title":"Phytother Res"},{"issue":"4","key":"10.1016\/j.prnil.2025.10.001_bib139","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1055\/s-2006-957450","article-title":"Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers","volume":"64","author":"Shoba","year":"1998","journal-title":"Planta Med"},{"issue":"1","key":"10.1016\/j.prnil.2025.10.001_bib140","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2021.101280","article-title":"Curcumin derivative 1, 2-bis [(3E, 5E)-3, 5-bis [(2-chlorophenyl) methylene]-4-oxo-1-piperidyl] ethane-1, 2-dione (ST03) induces mitochondria mediated apoptosis in ovarian cancer cells and inhibits tumor progression in EAC mouse model","volume":"15","author":"Koroth","year":"2022","journal-title":"Transl Oncol"},{"issue":"8","key":"10.1016\/j.prnil.2025.10.001_bib141","doi-asserted-by":"crossref","first-page":"4240","DOI":"10.1002\/ptr.8265","article-title":"Curcumin and nano-curcumin applications in psychiatric disorders","volume":"38","author":"Mohammadzadeh","year":"2024","journal-title":"Phytother Res"},{"issue":"12","key":"10.1016\/j.prnil.2025.10.001_bib142","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23126858","article-title":"Nano-liposomes double loaded with curcumin and tetrandrine: preparation, characterization, hepatotoxicity and anti-tumor effects","volume":"23","author":"Song","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.prnil.2025.10.001_bib143","article-title":"Development and evaluation of curcumin nano-niosomes for glioma-targeted therapy","volume":"15","author":"Qian","year":"2025","journal-title":"Sci Rep"}],"container-title":["Prostate International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2287888225000911?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2287888225000911?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T15:29:23Z","timestamp":1782314963000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2287888225000911"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":143,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S2287888225000911"],"URL":"https:\/\/doi.org\/10.1016\/j.prnil.2025.10.001","relation":{},"ISSN":["2287-8882"],"issn-type":[{"value":"2287-8882","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic potentials of curcumin in prostate cancer: a comprehensive review of pathways and clinical prospects","name":"articletitle","label":"Article Title"},{"value":"Prostate International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prnil.2025.10.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Asian Pacific Prostate Society. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}